A Systematic Review on the Contribution of Artificial Intelligence in the Development of Medicines for COVID-2019
Background: COVID-2019 pandemic lead to a raised interest on the development of new treatments through Artificial Intelligence (AI). Aim: to carry out a systematic review on the development of repurposed drugs against COVID-2019 through the application of AI. Methods: The Systematic Reviews and Meta...
Main Author: | Carla Pires |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-09-01
|
Series: | Journal of Personalized Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4426/11/9/926 |
Similar Items
-
Artificial intelligence-driven drug repurposing and structural biology for SARS-CoV-2
by: Kartikay Prasad, et al.
Published: (2021-01-01) -
Artificial intelligence approach fighting COVID-19 with repurposing drugs
by: Yi-Yu Ke, et al.
Published: (2020-08-01) -
Repurposing Approved Drugs for Guiding COVID-19 Prophylaxis: A Systematic Review
by: Bruno Silva Andrade, et al.
Published: (2020-12-01) -
Prediction of repurposed drugs for Coronaviruses using artificial intelligence and machine learning
by: Akanksha Rajput, et al.
Published: (2021-01-01) -
Repurposing Sigma-1 Receptor Ligands for COVID-19 Therapy?
by: José Miguel Vela
Published: (2020-11-01)